Sucraid is an oral enzyme replacement therapy of the genetically determined sucrase deficiency. The Food and Drug Administration (FDA) has approved Sucraid ® (sacrosidase) Oral Solution single-use ...
The FDA's Office of Prescription Drug Promotion issued an untitled letter to QOL Medical over two promotional emails for ...
Office of Prescription Drug Promotion (OPDP) sent an untitled letter to QOL Medical to “false or misleading” claims made in ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
A new study has found that genetic variants affecting sucrase, a digestive enzyme, are associated with an increased risk of irritable bowel syndrome (IBS). Researchers analyzed data from over 360,000 ...
Do you have IBS-like flare-ups after eating sweets made with regular white sugar, starches, and other foods like oranges, bananas, and cantaloupe (when these are low FODMAP choices)? You may need to ...
VERO BEACH, Fla., March 1, 2025 /PRNewswire/ -- QOL Medical, LLC, a ground-breaking rare disease pharmaceutical company, has announced Sucraid ® (sacrosidase) Oral Solution has been shown to be 81% ...
Sucrase-isomaltase (SI) is an intestinal enzyme critical for the digestion of dietary carbohydrates, particularly sucrose and starch. Previous studies from the Gastrointestinal Genetics team at CIC ...
Background: Congenital sucrase–isomaltase deficiency is a rare hereditary cause of chronic diarrhea in children. People with this condition lack the intestinal brush-border enzyme required for ...
The speedy Sucrase compiler is emerging as a potential alternative to the Babel JavaScript compiler for development purposes, if not for production builds. The developers behind the project claim that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results